Tower Research Capital (TRC)’s Fractyl Health GUTS Stock Holding History
Bought
Maintained
Sold
Other funds holding GUTS
6CM
Tower Research Capital (TRC)'s GUTS Position: Q3 2026 in Review
Tower Research Capital (TRC) sold out of Fractyl Health (GUTS) in Q3 2026, closing a stake of 2,302 shares — an estimated $21.9K sold.
Tower Research Capital (TRC) first reported a position in GUTS in Q1 2024 and held it in 9 quarters. The position peaked at $40.3K in Q1 2024. 75 funds tracked by Wall St. Rank hold GUTS as of Q3 2026.
- Tower Research Capital (TRC) reported no remaining Fractyl Health position as of Q3 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 2,302 Fractyl Health shares in Q3 2026, an estimated $21.9K.
- Tower Research Capital (TRC) first reported a position in Fractyl Health in Q1 2024 and held it in 9 quarters.
- Tower Research Capital (TRC)'s Fractyl Health position peaked at $40.3K in Q1 2024.
- 75 funds tracked by Wall St. Rank held Fractyl Health as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.